Answers are grounded in this paper and cite their sources.
Objective — to determine the association of basic demographic, clinical, and routine laboratory characteristics with the risk of adverse outcomes in patients with COVID-19. Materials and methods. Data of 320 patients hospitalized in the City Clinical Hospital No. 21 named after Prof. Ye. G. Popkova with a diagnosis of coronavirus disease19 (SARS-CoV2+ RNA)) were studied. Women — 156 (48.8 %), men — 164 (51.2 %), the mean age of the patients — (60.3 ± 13.6) years. Patients were divided into 2 groups: Group I — 270 (84.4 %) people who were discharged from the hospital with recovery or significant improvement in their condition, Group II — 50 (15.6 %) patients who died as a result of the disease (p = 0.010). The average period from the onset of the disease to hospitalization was 9 (7; 11) days. Statistical processing of the research results was carried out using the Statistica v. 6.1 software package. Results and discussion. Most of the deceased patients were older than 60 years — 36 (72.0 %) (p < 0.001). The maximum number of fatalities is in the age range of 60—69 years. Mortality among men was 1.5 times higher than among women — 30 (60.0 %) vs 20 (40.0 %) (p = 0.046). In the II group, the following were observed significantly more often: ischemic heart disease and hypertension — respectively 54.0 vs 20.7 % (p < 0.001) and 70.0 vs 50.0 % (p = 0.009); other heart diseases (OR — 7.23, rv = 0.202, p < 0.001), obesity (OR — 2.97, rv = 0.186, p < 0.001), diabetes (OR — 2.38, rv = 0.146; p = 0.009).The risk of mortality increased in the presence of cough (OR — 11.87, p = 0.012), fever (OR — 3.44, p < 0.001); lymphopenia (OR — 3.82, p < 0.001); hyperglycemia (OR — 4.69, p < 0.001); increased C-reactive protein (CRP) (OR — 5.96, p < 0.001), especially above 100 mg/l (OR from 39.86 to 52.35 at p < 0.01 and p < 0.001). However, thrombocytosis and lymphomonocytosis were more often observed during the benign course of the disease (respectively: p < 0.001, p = 0.051). A direct relationship between the probability of mortality and age (rs = 0.143, p = 0.011), respiratory rate (rs = 0.332, p < 0.001) and heart rate (rs = 0.159, p = 0.004) was revealed; fever (rs = 0.152, p = 0.006), quantitative indicators: segmented neutrophils (rs = 0.275, p < 0.001), urea (rs = 0.309, p < 0.001), urea nitrogen (rs = 0.300, p < 0.001), residual nitrogen (rs = 0.288, p < 0.001), creatinine (rs = 0.111, p = 0.047), glucose (rs = 0.273, p < 0.001), CRP (rs = 0.348, p < 0.001), prothrombin time (rs = 0.149, p = 0.008), international normalized ratio (rs = 0.193, p = 0.001). A inverse relationship was determined with blood oxygen saturation (rs = – 0.431, p < 0.001); levels of lymphocytes, bands, platelets and prothrombin index (respectively: rs = – 0.278, p < 0.001; rs = – 0.118, p = 0.034; rs = – 0.223, p < 0.001; rs = – 0.170, p = 0.002). Conclusions. The following are associated with in-hospital mortality in patients with COVID-19: older age, coronary heart disease, stage III hypertension, diabetes, stage III obesity, clinical and laboratory signs: fever, shortness of breath, cough, lymphopenia, CRP content in the blood more than 100 mg/l, hyperglycemia, increased markers of kidney damage and hypercoagulation. The obtained results may be useful for predicting the course of the coronavirus disease.
No takes yet. Share an insight, caveat, or question.
Bilokon et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: